At1g58050 Antibody

Shipped with Ice Packs
In Stock

Product Specs

Buffer
Preservative: 0.03% ProClin 300; Constituents: 50% Glycerol, 0.01M PBS, pH 7.4
Form
Liquid
Lead Time
14-16 week lead time (made-to-order)
Synonyms
At1g58050 antibody; T15M6.6DExH-box ATP-dependent RNA helicase DExH4 antibody; chloroplastic antibody; EC 3.6.4.13 antibody
Target Names
At1g58050
Uniprot No.

Target Background

Database Links

KEGG: ath:AT1G58050

STRING: 3702.AT1G58050.1

UniGene: At.52250

Protein Families
DExH box helicase family
Subcellular Location
Plastid, chloroplast.

Q&A

What experimental approaches are recommended for validating the specificity of At1g1g58050 antibodies in Arabidopsis thaliana?

Three orthogonal validation methods are essential:

  • Western Blot with Knockout Controls: Compare band patterns in wild-type (WT) plants versus CRISPR/Cas9-generated At1g58050 knockout lines. A valid antibody should show absence of the target band (~75 kDa predicted molecular weight) in knockout samples. As demonstrated in PMC3523722, non-specific binding often persists in knockout models, necessitating secondary validation .

  • Immunohistochemistry with Tissue-Specific Promoters: Cross-reference staining patterns in transgenic lines expressing At1g58050 under tissue-specific promoters (e.g., APL for phloem). Discordant localization signals indicate off-target binding .

  • Immunoprecipitation-Mass Spectrometry (IP-MS): Identify co-purified proteins using high-resolution LC-TOF systems (Agilent 6210 TOF). Table 1 shows typical parameters for antibody-antigen complex analysis .

Table 1: LC-TOF MS Parameters for IP-MS Validation

ParameterSetting
Column Temperature90°C
Flow Rate500 µL/min
Gradient Duration9 min (20-90% ACN)
Ionization ModeESI+ (5500 V capillary)
Mass Range500-3200 m/z

How should researchers troubleshoot inconsistent Western blot results when using At1g58050 antibodies across different plant growth stages?

Develop a staged normalization protocol:

  • Endogenous Reference Controls: Use constitutively expressed RNA helicases (e.g., At3g22330) as loading controls rather than traditional housekeeping proteins like actin, which show developmental stage-dependent expression .

  • Cross-Reactivity Profiling: Pre-absorb antibodies against leaf, root, and flower protein extracts separately. PMC3523722 found 38-48 kDa non-target bands persist even in knockout models, requiring subtractive absorption .

  • Quantitative PCR Correlation: Measure At1g58050 mRNA levels (primers: F-5’-CGATCTAGCTAGCACCGTCA-3’, R-5’-TGCATCGATGGTTCGAGTCT-3’) alongside protein expression. Discrepancies >2-fold suggest antibody specificity issues .

What computational strategies improve At1g58050 antibody affinity while maintaining cross-reactivity with orthologs in Brassica species?

Adapt the GUIDE (Generative Unconstrained Intelligent Drug Engineering) platform:

  • Paratope Optimization: Introduce strategic mutations (e.g., SL32W, TL59E) in complementarity-determining regions (CDRs) to enhance binding to conserved epitopes across Brassicaceae. PMC11111397 achieved 50-fold IC50 improvements against Omicron variants using similar approaches .

  • Multi-Objective Affinity Modeling: Simultaneously optimize for:

    • Binding energy to At1g58050 (ΔG ≤ -10 kcal/mol)

    • Structural stability (Tm ≥ 65°C)

    • Ortholog recognition (≥80% sequence identity to B. napus homologs)

  • In Silico Cross-Reactivity Screening: Use AlphaFold2-predicted structures of non-target plant proteins to eliminate designs with putative off-target binding .

Table 2: Computational Design Outcomes for Antibody Engineering

Design ParameterParental AntibodyOptimized Variant 2130-1-0114-112
ΔG (kcal/mol)-8.2-12.7
Tm (°C)61.468.9
Cross-Reactivity Score0.470.09

How can researchers resolve contradictions between ChIP-seq data and immunohistochemistry results for At1g58050 localization?

Implement a four-step reconciliation framework:

  • Epitope Accessibility Analysis: Treat fixed tissues with protein unfolding agents (6 M urea, 10 min) before immunostaining. PMC3523722 demonstrated that cryptic epitopes account for 73% of false-negative IHC results .

  • Cross-Validation with GFP-Tagged Lines: Compare antibody-derived signals with fluorescence patterns in At1g58050pro::GFP transgenic plants under identical fixation conditions.

  • Chromatin Fractionation Western Blot: Isolate nuclear (NE-PER kit) and cytoplasmic fractions. At1g58050’s RNA helicase function predicts dual localization; absence in nuclear fractions invalidates ChIP-seq data.

  • Multiplexed Ion Beam Imaging (MIBI): Resolve subcellular localization at 50 nm resolution using metal-tagged secondary antibodies, bypassing optical diffraction limits.

What protocols enable simultaneous quantification of At1g58050 protein isoforms and phosphorylation states?

Employ a two-dimensional LC-MS/MS workflow:

  • Immunoaffinity Enrichment: Couple antibodies to NHS-activated Sepharose beads (Cytiva) using 0.1 M sodium phosphate buffer (pH 7.4). Elute with 0.1% TFA/ACN .

  • Phosphopeptide Enrichment: Treat tryptic digests with TiO2 microspheres (5 µm, GL Sciences) in 80% ACN/6% TFA.

  • Data-Independent Acquisition (DIA): Acquire MS/MS spectra in 4 m/z isolation windows (Agilent 6210 TOF). Table 3 details gradient conditions .

Table 3: 2D LC Parameters for Phosphoform Resolution

DimensionColumnGradientDetection
FirstZorbax 300SB-C18 (5 µm)20-90% ACN/0.1% FA over 9 minUV 280 nm
SecondPolyCAT A (3 µm)10-40% ACN/10 mM KH2PO4TOF-MS (500-3200 m/z)

Quick Inquiry

Personal Email Detected
Please use an institutional or corporate email address for inquiries. Personal email accounts ( such as Gmail, Yahoo, and Outlook) are not accepted. *
© Copyright 2025 TheBiotek. All Rights Reserved.